These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 17758849)

  • 21. Adverse effects of lupus anticoagulant positive blood sera on placental viability can be prevented by heparin in vitro.
    Bose P; Black S; Kadyrov M; Bartz C; Shlebak A; Regan L; Huppertz B
    Am J Obstet Gynecol; 2004 Dec; 191(6):2125-31. PubMed ID: 15592302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the in vivo anticoagulant properties of standard heparin and the highly selective factor Xa inhibitors antistasin and tick anticoagulant peptide (TAP) in a rabbit model of venous thrombosis.
    Vlasuk GP; Ramjit D; Fujita T; Dunwiddie CT; Nutt EM; Smith DE; Shebuski RJ
    Thromb Haemost; 1991 Mar; 65(3):257-62. PubMed ID: 2048051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standard and method independent units for heparin anticoagulant activities.
    Hemker HC; Béguin S
    Thromb Haemost; 1993 Nov; 70(5):724-8. PubMed ID: 8128425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is heparin the ideal anticoagulant for cardiopulmonary bypass? Dermatan sulphate may be an alternate choice.
    Brister SJ; Ofosu FA; Heigenhauser GJ; Gianese F; Buchanan MR
    Thromb Haemost; 1994 Apr; 71(4):468-73. PubMed ID: 8052965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of epsilon-aminocaproic acid derivatives on the anticoagulant activity of heparin.
    Midura-Nowaczek K; Bruzgo I; Worowski K; Roszkowska-Jakimiec W
    Rocz Akad Med Bialymst; 1998; 43():228-31. PubMed ID: 9972059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local heparin, superficial vein thrombosis.
    Cesarone MR; Belcaro G; Corsi M; Ippolito E; Errichi S; Di Renzo A; Ledda A; Fano F; Cacchio M; Adovasio R
    Angiology; 2007; 58 Suppl 1():36S-40S. PubMed ID: 17478881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Audit of anticoagulant therapy of pulmonary embolus, deep vein thrombosis and thrombophlebitis.
    Meinhold JM; Reale EO; Miller WA
    Am J Hosp Pharm; 1979 Feb; 36(2):214-8. PubMed ID: 420210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of N-deacetylation and N-desulfation of heparin on its anticoagulant activity and in vivo disposition.
    Bjornsson TD; Schneider DE; Hecht AR
    J Pharmacol Exp Ther; 1988 Jun; 245(3):804-8. PubMed ID: 3164387
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HEPARIN AS AN ANTICOAGULANT FOR PERMEABILITY STUDIES.
    Hunter FR; Stringer LD; Weiss HD
    Science; 1940 Jun; 91(2372):579. PubMed ID: 17758849
    [No Abstract]   [Full Text] [Related]  

  • 30. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.